A first of a kind joint meeting organized by EORTC, the NCI, the EMA and the AACR
14M Genomics and the EORTC collaborate on genomic profiling for clinical trials
Program for IBCD 2015 offers plenty for all cancer drug development stakeholders
What does the future hold for treating patients with locally advanced breast cancer?
Improving treatment for patients with recurrent glioblastoma
EORTC opens trial for patients with high grade undifferentiated uterine sarcoma, a rare cancer
Saskia Litière, Biostatistician at the EORTC, discusses the ongoing evaluation of RECIST with Helen Saul
Avenue Emmanuel Mounier, 83/11